Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPtimal TIming of Staged Complete RevascularizatiON in ST-Segment Elevation Myocardial Infarction With Multivessel Disease: The OPTION-STEMI2 Trial

NCT07741721 is registered in ClinicalTrials.gov with Chonnam National University Hospital as lead sponsor.

NCT NCT07741721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPtimal TIming of Staged Complete RevascularizatiON in ST-Segment Elevation Myocardial Infarction With Multivessel Disease: The OPTION-STEMI2 Trial
Lead sponsor
Chonnam National University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
July 31, 2035
Enrollment
1,252 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction (mi)